NeuroSeriesLive

CME Presentations

From Novice to Expert: A Series in Multiple Sclerosis Management


Presentations


Speakers

  • Amy Perrin Ross, APN, MSN, CNRN, MSCN

    Amy Perrin Ross, APN, MSN, CNRN, MSCN

    Amy Perrin Ross, APN, MSN, CNRN, MSCN

    Advanced Practice Nurse, Neuroscience Program Coordinator

    Amy Perrin Ross, APN, MSN, CNRN, MSCN, is currently the president of the International Organization of Multiple Sclerosis Nurses, and is the Neuroscience Program Coordinator at Loyola University Medical Center in Maywood, Illinois. She is involved in various organizations, including the Consortium of Multiple Sclerosis Centers, the National Multiple Sclerosis Society, and the Multiple Sclerosis Association of America. Ms Perrin Ross has been active in neuroscience clinical research for over 20 years. She speaks at numerous meetings and conferences, and has written several articles and book chapters on MS and dementia. She earned her BSN degree from Loyola University School of Nursing in Chicago, Illinois, and her MSN degree from Loyola University’s Graduate School of Nursing.
  • Jerry S. Wolinsky, MD

    Jerry S. Wolinsky, MD

    Jerry S. Wolinsky, MD

    Emeritus Professor in Neurology

    Jerry S. Wolinsky, MD, is Professor Emeritus in the Department of Neurology at the McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth). He held the Bartels Family and Opal C. Rankin Professorships of Neurology at UTHealth, where he served as director of the Multiple Sclerosis Research Group and the Magnetic Resonance Imaging Analysis Center, and as a member of the graduate faculty of the Graduate School of Biomedical Sciences. Dr Wolinsky focuses on the design, implementation, conduct and analysis of clinical trials of multiple sclerosis, and basic and applied research in quantitative MRI analysis and MR spectroscopic imaging. He received his medical degree from the University of Illinois College of Medicine in Chicago.
  • James D. Bowen, MD

    James D. Bowen, MD

    James D. Bowen, MD

    Clinical Associate Professor of Neurology

    James D. Bowen, MD, is medical director for the multiple sclerosis center at the Swedish Neuroscience Institute in Seattle, Washington, and is a clinical associate professor in the Department of Neurology at the University of Washington. Dr Bowen earned his medical degree at The Johns Hopkins University in Baltimore, Maryland, and completed a two-year residency in internal medicine and neurology at the University of Washington in Seattle. He is chair of the Professional Advisory Committee of the Greater Northwest Chapter of the National MS Society. Dr Bowen is a recipient of the Physician Leadership Award from the Swedish Medical Center, and has published more than 120 peer-reviewed journal articles, numerous book chapters and abstracts with a focus on multiple sclerosis.
  • Patricia K. Coyle, MD, FAAN, FANA

    Patricia K. Coyle, MD, FAAN, FANA

    Patricia K. Coyle, MD, FAAN, FANA

    Professor & Vice Chair (Clinical Affairs) Department of Neurology

    Patricia K. Coyle, MD, FAAN, FANA, is professor and vice chair (clinical affairs) of neurology, and director of the Multiple Sclerosis Comprehensive Care Center at Stony Brook University Medical Center in Stony Brook, New York. Dr Coyle is currently involved in various therapeutic trials testing new immunotherapies for multiple sclerosis (MS), as well as studies addressing neurologic aspects of Lyme disease. Her areas of expertise include Lyme disease and neurologic infections, cerebrospinal fluid, therapeutics and neuroimmunology, and she has authored several articles on the clinical/basic research aspects of MS and neurologic infections. She earned her MD from the Johns Hopkins University School of Medicine in Baltimore, Maryland, where she also completed her residency and fellowship.
  • Marie Namey, APRN, MSCN

    Marie Namey, APRN, MSCN

    Marie Namey, APRN, MSCN

    Clinical Nurse Specialist, Mellen Center for MS Treatment & Research

    Marie A. Namey, APRN, MSCN, is a clinical nurse specialist at the Mellen Center for Multiple Sclerosis Treatment and Research at the Cleveland Clinic Foundation in Ohio. She earned her MSN degree from the Frances Payne Bolton School of Nursing at Case Western Reserve University in Cleveland, and her BSN degree from Villa Maria College in Erie, Pennsylvania. Ms Namey is a member of the local Multiple Sclerosis Society Chapter’s Professional Advisory Committee, a member of the Healthcare Advisory Council for the Multiple Sclerosis Association of America, and is a founding member and past president of the International Organization of Multiple Sclerosis Nurses. She has published several articles, and speaks for patient and professional groups on aspects of multiple sclerosis care.

CME Information

From Novice to Expert: A Series in Multiple Sclerosis Management


LEARNING OBJECTIVES

Session 1:

  • Compare and contrast established and emerging disease modifying therapies for patients with relapsing forms of MS in order to facilitate individualized treatment decisions
  • Develop an appropriate long-term treatment plan that considers the variable characteristics of each patient based on a model of personalized care and shared decision-making
  • Develop strategies that will enhance patient education and resultant treatment adherence that include technology and effective patient centered communication strategies that accommodate patient choice and lifestyle

Session 2:

  • Summarize the relative therapeutic potential of monoclonal antibodies for the treatment of MS
  • Compare and contrast the mechanisms, risks, and benefits of new and emerging monoclonal antibodies in the management of MS

Session 3:

  • Summarize the relative safety, efficacy and tolerability of available DMTs that may be used for escalation or induction therapy in patients with MS
  • Identify agents that may be utilized as induction regimens in select patients with MS

Acknowledgement

This activity is supported by educational grants from AbbVie, Biogen, Celgene, and Sanofi Genzyme.

Tuition

Complimentary

GENERAL CME/CNE/CE INFORMATION

In order to successfully complete this continuing education activity, the participant must register for the activity, attend the activity, and complete the online Evaluation and Claim for Credit form.

Date of Release/Expiration

Live Activity

April 5, 2018

Enduring Material

The enduring material will be available from April 5, 2018 to April 5, 2019

Target Audience

Neurologists, internists, family physicians, primary care clinicians, physician assistants, nurse practitioners, nurses, and pharmacists involved in the care of patients with MS.

Accreditation and Credit Information

In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC), and Platform Q Health Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The CMSC designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Certificate of Completion

A Certificate of Completion may be given upon completion of course requirements enabling you to register your credit with the appropriate licensing boards or associations. You may apply for other accreditations using the procedure established by the specific organization

Disclosure of Unlabeled Use

CMSC and Platform Q Health Education require faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

There are no fees to participate in this activity. To participate in the activity, go to http://www.cmscscholar.com/ or www.NeuroSeriesLive.com. To receive credit, participants must (1) read the activity front matter, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

DISCLOSURE OF FINANCIAL RELATIONSHIPS

It is the policy of CMSC, NPA, and Platform Q Health Education to ensure balance, independence, objectivity, and scientific rigor in all educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed any relevant financial relationships they or their spouse/life partner have within the previous 12 months with manufacturers of any commercial products/devices and/or providers of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. All presentations were reviewed by an independent clinician with no relevant financial relationships for the purpose of resolution of any identified conflict of interest and a determination of evidence-base and fair balance.

Faculty Disclosures

The faculty reported the following financial relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

James D. Bowen, MD served as faculty for this activity. He has received consulting fees from Biogen IDEC, EMD Serono, Genentech, and Novartis. He has served on the speaker’s bureau for Acorda Therapeutics, Biogen IDEC, EMD Serono, Genentech, Novartis, and Teva Neuroscience. He has received funding for research from Alexion, Alkermes, Biogen IDEC, Celgene, Genzyme, Genentech, Novartis, and TG Therapeutics. He has ownership interest in Amgen.

Patricia K. Coyle, MD served as faculty for this activity. She has received consulting fees from Accordant, Acorda, Bayer, Biogen, Celgene, Genentech/Roche, Genzyme/Sanofi, Novartis, and Serono. She has received funding for research from Actelion, Genentech/Roche, MedDay, NINDS, and Novartis.

Marie Namey, APRN, MSCN served as faculty for this activity. She has received consulting fees from Biogen, Genentech, Novartis, and Sanofi-Genzyme. She has served on the speaker’s bureau for Acorda Therapeutics, Biogen, EMD Serono, Sanofi- Genzyme, Novartis, Teva Neuroscience.

Amy Perrin Ross, APN, MSN, CNRN, MSCN served as faculty for this activity. She has received consulting fees from Bayer, Celgene, EMD Serono, Genentech, Genzyme, Mallinckrodt, Roche, and TEVA. She has served on the speaker’s bureau for Acorda, Biogen, EMD Serono, Genentech, Genzyme, Mallinckrodt, Novartis, and TEVA.

Jerry S. Wolinsky, MD, served as faculty for this activity. He has received royalties from Millipore (Chemicon International) Corporation, and consulting fees from Actelion, Alkermes, Biogen, Celgene, Clene Nanomedicine, EMD Serono, Forward Pharma, GeNeuro, MedDay, Novertis, Otsuka, PTC Therapeutics, Roche Genentech, and Sanofi Genzyme.

June Halper, MSN, APN-C, MSCN, FAAN served as planner and reviewer for this activity. She has disclosed no relevant financial relationships.

Laurie Scudder, DNP, NP, served as nurse planner and reviewer for this activity. She has disclosed no relevant financial relationships.

All other CMSC and Platform Q Health Education staff who are in a position to influence content have disclosed no relevant financial relationships.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Contact Information

If you have questions about this CME/CNE activity, please contact the CMSC at education@mscare.org or 201-487-1050

.